A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia

NCT00001567 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

Hairy Cell Leukemia

Interventions

DRUG: Roferon-A

Sponsor

National Cancer Institute (NCI)